Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Recent Developments in Cancer Immunotherapy
The field of cancer immunotherapy has evolved dramatically in recent years. As increasingly greater options for, and combinations of, cancer immunotherapy become available, clinicians need to stay up-to-date on the role of immunotherapy in a rapidly changing therapeutic landscape.
Category
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Update on Management of Acute Lymphoblastic Leukemia
Despite the high rate of complete remission for patients with ALL, a majority of patients will develop relapsed or refractory disease. Recent advances expanding available therapeutic options could change the standard of care for these patients.
Category
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Renal Cell Carcinoma
Management of Renal Cell Carcinoma (RCC)
Category
  • Kidney Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Optimizing Small Molecule Inhibitor Therapy for Relapsed/Refractory B-cell Lymphomas
The goal of this program is to ensure that members of the interprofessional oncology care team, including physicians, nurses, pharmacists and other relevant health care professionals, have the knowledge and skills necessary to apply the standards of care to their practice and health care setting
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018 Nursing Program Webinar Series - Management of Cardiovascular Toxicities Associated with TKI Therapy
Cardiovascular toxicities can be managed effectively with appropriate therapy if they are recognized early.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Management of Bone Health in Patients with Cancer
With the improved effectiveness of cancer treatment, more and more patients are surviving longer and may experience fractures as a long-term complication of bone loss.
Category
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Hepatocellular Carcinoma
Management of Advanced Hepatocellular Carcinoma
Category
  • Hepatocellular Carcinoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Breast Cancer, Version 3.2018
These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer.
Category
  • Breast Cancer
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • AAPA Category 1 CME credit
  • Participation
NCCN Task Force Report: Chimeric Antigen Receptor T-Cell Therapy
Patients with relapsed or refractory (R/R) cancers have a poor prognosis and limited treatment options.
Category
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
CAR T-Cell Therapy: Recent Advances and Future Considerations
Patients with relapsed or refractory (R/R) cancers have a poor prognosis and limited treatment options.
Category
  • Acute Lymphoblastic Leukemia
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages